West Pharmaceutical Servi...

222.07
-3.99 (-1.77%)
At close: Mar 28, 2025, 3:59 PM
220.91
-0.52%
After-hours: Mar 28, 2025, 06:51 PM EDT

West Pharmaceutical Services Statistics

Share Statistics

West Pharmaceutical Services has 72.29M shares outstanding. The number of shares has increased by -1.07% in one year.

Shares Outstanding 72.29M
Shares Change (YoY) -1.07%
Shares Change (QoQ) -0.16%
Owned by Institutions (%) 95.73%
Shares Floating 71.86M
Failed to Deliver (FTD) Shares 789
FTD / Avg. Volume 0.08%

Short Selling Information

The latest short interest is 1.5M, so 2.07% of the outstanding shares have been sold short.

Short Interest 1.5M
Short % of Shares Out 2.07%
Short % of Float 2.09%
Short Ratio (days to cover) 2.78

Valuation Ratios

The PE ratio is 48.53 and the forward PE ratio is 45.66. West Pharmaceutical Services's PEG ratio is -3.13.

PE Ratio 48.53
Forward PE 45.66
PS Ratio 8.26
Forward PS 4.5
PB Ratio 8.91
P/FCF Ratio 86.51
PEG Ratio -3.13
Financial Ratio History

Enterprise Valuation

West Pharmaceutical Services Inc. has an Enterprise Value (EV) of 25.62B.

EV / Earnings 51.99
EV / Sales 8.85
EV / EBITDA 34.44
EV / EBIT 44.95
EV / FCF 92.68

Financial Position

The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.11.

Current Ratio 2.79
Quick Ratio 2.11
Debt / Equity 0.11
Total Debt / Capitalization 10.13
Cash Flow / Debt 2.16
Interest Coverage 189.97

Financial Efficiency

Return on equity (ROE) is 0.18% and return on capital (ROIC) is 15.59%.

Return on Equity (ROE) 0.18%
Return on Assets (ROA) 0.14%
Return on Capital (ROIC) 15.59%
Revenue Per Employee $272,943.4
Profits Per Employee $46,481.13
Employee Count 10,600
Asset Turnover 0.79
Inventory Turnover 5.03

Taxes

Income Tax 107.5M
Effective Tax Rate 0.18

Stock Price Statistics

The stock price has increased by -42.9% in the last 52 weeks. The beta is 1.09, so West Pharmaceutical Services's price volatility has been higher than the market average.

Beta 1.09
52-Week Price Change -42.9%
50-Day Moving Average 268.47
200-Day Moving Average 302.22
Relative Strength Index (RSI) 39.77
Average Volume (20 Days) 967.89K

Income Statement

In the last 12 months, West Pharmaceutical Services had revenue of 2.89B and earned 492.7M in profits. Earnings per share was 6.75.

Revenue 2.89B
Gross Profit 998.5M
Operating Income 569.9M
Net Income 492.7M
EBITDA 743.9M
EBIT 569.9M
Earnings Per Share (EPS) 6.75
Full Income Statement

Balance Sheet

The company has 484.6M in cash and 302.3M in debt, giving a net cash position of 182.3M.

Cash & Cash Equivalents 484.6M
Total Debt 302.3M
Net Cash 182.3M
Retained Earnings 3.96B
Total Assets 3.64B
Working Capital 987.7M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 653.4M and capital expenditures -377M, giving a free cash flow of 276.4M.

Operating Cash Flow 653.4M
Capital Expenditures -377M
Free Cash Flow 276.4M
FCF Per Share 3.79
Full Cash Flow Statement

Margins

Gross margin is 34.51%, with operating and profit margins of 19.7% and 17.03%.

Gross Margin 34.51%
Operating Margin 19.7%
Pretax Margin 20.24%
Profit Margin 17.03%
EBITDA Margin 25.71%
EBIT Margin 19.7%
FCF Margin 9.55%

Dividends & Yields

WST pays an annual dividend of $0.83, which amounts to a dividend yield of 0.37%.

Dividend Per Share $0.83
Dividend Yield 0.37%
Dividend Growth (YoY) 5%
Payout Ratio 12.43%
Earnings Yield 2.99%
FCF Yield 1.69%
Dividend Details

Analyst Forecast

The average price target for WST is $355, which is 57.1% higher than the current price. The consensus rating is "Buy".

Price Target $355
Price Target Difference 57.1%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Stock Splits

The last stock split was on Sep 27, 2013. It was a forward split with a ratio of 2:1.

Last Split Date Sep 27, 2013
Split Type forward
Split Ratio 2:1

Scores

Altman Z-Score 13.63
Piotroski F-Score 6